- Home
- TOVX vs DBL Comparison
TOVX vs DBL Comparison
Compare TOVX & DBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- DBL
- Stock Information
- Founded
- TOVX 2001
- DBL 2011
- Country
- TOVX United States
- DBL United States
- Employees
- TOVX N/A
- DBL N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- DBL
- Sector
- TOVX Health Care
- DBL
- Exchange
- TOVX Nasdaq
- DBL Nasdaq
- Market Cap
- TOVX 3.5M
- DBL 284.1M
- IPO Year
- TOVX 2006
- DBL N/A
- Fundamental
- Price
- TOVX $1.14
- DBL $15.33
- Analyst Decision
- TOVX Strong Buy
- DBL
- Analyst Count
- TOVX 1
- DBL 0
- Target Price
- TOVX $6.00
- DBL N/A
- AVG Volume (30 Days)
- TOVX 96.3K
- DBL 61.0K
- Earning Date
- TOVX 11-12-2024
- DBL 01-01-0001
- Dividend Yield
- TOVX N/A
- DBL 8.67%
- EPS Growth
- TOVX N/A
- DBL N/A
- EPS
- TOVX N/A
- DBL N/A
- Revenue
- TOVX N/A
- DBL N/A
- Revenue This Year
- TOVX N/A
- DBL N/A
- Revenue Next Year
- TOVX N/A
- DBL N/A
- P/E Ratio
- TOVX N/A
- DBL N/A
- Revenue Growth
- TOVX N/A
- DBL N/A
- 52 Week Low
- TOVX $1.14
- DBL $13.75
- 52 Week High
- TOVX $17.00
- DBL $15.70
- Technical
- Relative Strength Index (RSI)
- TOVX 36.15
- DBL 36.15
- Support Level
- TOVX $1.23
- DBL $15.42
- Resistance Level
- TOVX $1.21
- DBL $15.76
- Average True Range (ATR)
- TOVX 0.07
- DBL 0.12
- MACD
- TOVX 0.01
- DBL -0.02
- Stochastic Oscillator
- TOVX 0.00
- DBL 10.20
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest
Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.